Published in Health Business Week, February 16th, 2007
Originally formed in partnership with Cardinal Health in 2004, the 14-member sales force promotes Acetadote to hospitals and poison control centers around the country. Acetadote is the first injectable drug in the U.S. for the treatment of acetaminophen overdose, and is currently stocked in more than 2,600 hospitals nationwide.
"This is an exciting step in the development of our company," said A.J. Kazimi, CEO of Cumberland Pharmaceuticals. "As we continue to grow, we are working to strengthen our infrastructure and enhance...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.